Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Crescent Biopharma, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +5 vs. Q3 2024
- Shares held
- 30.4M
- +12.6M (+70.6%) vs. Q3 2024
- Total value
- $7.56M
- +$4.55M (+151.6%) vs. Q3 2024
- New holders
- 16
- 6 more added
- Sold out
- 11
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Acadian Asset Management LLC | 1,096 | $0 | 0.00% | −356,343−99.7% | Reduced |
| Royal Bank of Canada | 2,000 | $0 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 76 | $19 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 136 | $34 | 0.00% | −5−3.5% | Reduced |
| BNP Paribas Arbitrage, SA | 481 | $120 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 761 | $190 | 0.00% | +297+64.0% | Added |
| Truvestments Capital LLC | 1,309 | $326 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 4,755 | $1.18K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 5,176 | $1.29K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 6,501 | $1.62K | 0.00% | +6,501 | New |
| SBI Securities Co., Ltd. | 6,942 | $1.73K | 0.00% | +6,942 | New |
| HBK Sorce Advisory LLC | 11,718 | $2.92K | 0.00% | +11,718 | New |
| 1 North Wealth Services LLC | 12,000 | $2.99K | 0.00% | +12,000 | New |
| Baader Bank INC | 13,966 | $3.11K | 0.00% | +3,294+30.9% | Added |
| Pine Valley Investments Ltd Liability Co | 12,520 | $3.12K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 13,760 | $3.43K | 0.00% | +13,760 | New |
| Millennium Management LLC | 14,419 | $3.59K | 0.00% | −4,446−23.6% | Reduced |
| Tower Research Capital LLC (TRC) | 19,559 | $4.87K | 0.00% | +19,559 | New |
| Group One Trading, L.P. | 23,369 | $5.82K | 0.00% | −14,648−38.5% | Reduced |
| JustInvest LLC | 26,304 | $6.55K | 0.00% | +26,304 | New |
| Ground Swell Capital, LLC | 33,230 | $8.27K | 0.02% | +33,230 | New |
| Ieq Capital, LLC | 38,363 | $9.55K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 40,765 | $10.2K | 0.00% | +40,765 | New |
| Renaissance Technologies LLC | 41,153 | $10.2K | 0.00% | −739,947−94.7% | Reduced |
| Intellectus Partners, LLC | 45,965 | $11.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 58,854 | $14.7K | 0.00% | +58,854 | New |
| XTX Topco Ltd | 64,243 | $16.0K | 0.00% | +39,314+157.7% | Added |
| Northern Trust Corp | 116,985 | $29.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 179,265 | $44.6K | 0.00% | 00.0% | Unchanged |
| Caxton Corp | 203,578 | $50.9K | 0.31% | +203,578 | New |
| UBS Group AG | 228,868 | $57.0K | 0.00% | +160,428+234.4% | Added |
| ADAR1 Capital Management, LLC | 331,827 | $82.6K | 0.02% | +286,127+626.1% | Added |
| Jefferies Financial Group Inc. | 423,777 | $105.5K | 0.00% | +423,777 | New |
| Geode Capital Management, LLC | 521,223 | $129.8K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 728,637 | $181.4K | 0.00% | +779+0.1% | Added |
| Wellington Management Group LLP | 1,413,402 | $351.9K | 0.00% | +1,413,402 | New |
| Vanguard Group Inc | 2,670,208 | $664.9K | 0.00% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,000,000 | $747.0K | 0.05% | +3,000,000 | New |
| Adage Capital Partners GP, L.L.C. | 5,091,231 | $1.27M | 0.00% | +5,091,231 | New |
| Logos Global Management LP | 5,400,000 | $1.34M | 0.16% | +5,400,000 | New |
| BVF Inc | 9,544,262 | $2.38M | 0.08% | 00.0% | Unchanged |
| Siren, L.L.C. | 0 | $0 | 0.00% | −1,965,114−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −248,958−100.0% | Sold out |
| HCR Wealth Advisors | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −83,725−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −44,646−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −30,700−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −32,324−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,158−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,542−100.0% | Sold out |
| Tobias Financial Advisors, Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,506−100.0% | Sold out |